Visian ICL at Eye Health Partners

Eye Health Partners is pleased to offer the Visian ICL in our refractive surgery options. The Visian ICL is an Implantable Contact Lens for patients with moderate to high degrees of myopia (nearsightedness). This lens allows us to treat patients who would not otherwise be candidates for traditional refractive procedures like LASIK or PRK.

Proven Outcomes

View VideoThe Visian ICL has been shown to provide greater predictability of outcome for patients with higher amounts of myopia. In fact, with the Visian ICL the predicted outcome can be achieved 90 percent of the timeⁱ. At Eye Health Partners, our patients have enjoyed the same superior outcomes with 20/20 vision or better – sometimes just one hour postoperatively! Not only do they achieve 20/20 vision, but also the quality of vision provided by the Visian ICL has been shown to be greater than other refractive procedures for high myopia.ⁱⁱ

The FDA performed a three-year follow-up study in 2004. Based on the examination of 526 eyes, the following results were reportedⁱⁱⁱ

• » 99 percent of patients were satisfied/very satisfied with their results.
• » 98.3 percent of patients had uncorrected visual acuity of 20/40 or better.
• » Once vision was corrected, the correction was stable and did not change over the follow up period.
• » Additionally, the incidence of glare, halos, double vision, night vision problems, and night driving difficulties decreased or remained unchanged from before surgery.

For more information on the Visian ICL please also visit www.visianinfo.com or contact us!

__________________________________________________________

ⁱSanders D, Vukich J. "Comparison of Implantable Contact Lens and Laser Assisted In Situ Keratomileusis for Moderate to High Myopia". CORNEA; May 2003; 22: 324-330.

ⁱⁱSarver EJ, Sanders DR, Vukich, JA. Image quality in myopic eyes corrected with laser in situ keratomileusis and phakic intraocular lens. J Refract Surg. 2003;19(4):397-404.

ⁱⁱⁱICL in Treatment of Myopia (ITM) Study Group. United States Food and Drug Administration clinical trial of the Implantable Collamer Lens (ICL) for moderate to high myopia. Ophthalmology. 2004;111:1683-1692

Eye Health Partners & Vision America specialists are committed to providing exemplary patient care in a safe, comfortable environment. They specifically designed their facilities with an emphasis on patient safety while housing state-of-the-art technology.